Solid Biosciences Inc.
Nasdaq: SLDBBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0001707502
TickerSLDB
ExchangeNasdaq
SIC2836
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2022-12-31
$8.09M
-40.6% YoY
Net Income
—
—
Total AssetsFY2025-12-31
$232.54M
+23.3% YoY
EquityFY2025-12-31
$180.01M
+31.2% YoY
Shares OutstandingFY2025-12-31
98.39M
—
Operating Cash FlowFY2025-12-31
-$156.29M
-56.3% YoY
Market
Market
SLDBClose price
$8.33
Market cap
$820.09M
delayed EOD · as of 2026-06-18
Short interest & fails
Cost to borrow0.41%1.8M shares availablegeneral collateral
Short-sale volume
FINRA Reg SHO · daily19.6%
short of total volume · 2026-06-18
2026-06-1819.6%
2026-06-1752.3%
2026-06-1648.4%
2026-06-1549.8%
2026-06-1253.6%
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $8.09M | — | — | — | — | — |
| Total Assets | $260.25M | $164.94M | $188.66M | $232.54M | +23.3% | — |
| Equity | $211.67M | $126.48M | $137.25M | $180.01M | +31.2% | — |
| Operating Cash Flow | -$97.98M | -$94.18M | -$100.01M | -$156.29M | -56.3% | — |
| Shares Outstanding | — | — | — | 98.39M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001707502